RE: Simultaneous drug and metabolite POPPK

From: Jun Shi Date: February 13, 2007 technical Source: mail-archive.com
Mike, This depends on the purpose of the modeling and the information available. Usually, we only have Parent and Met concentration data after oral administration, therefore, we can't estimate the true disposition parameters. We can get CL/F and V/F for parent, but we can get nothing more than apparent Production rate constant and Elimination rate constant for Met. In this case, converting the data to micromolar unit or not is not critical. e.g. Let's begin from the differential equation below: DADT(3)=KMP(iv)*A(2)-KME*A(3) Eq 1 where A(2) is the amount of parent (mg), A(3) is the amount of metabolite (mg). KmP is the production rate of the metabolite. Because the distribution volume of Met (V3) is unobtainable (no IV data of Met), we have to convert dA/dt to dC/dt and divide both sides of Eq 1 by V3 as follows: DADT(3)/V3=KMP(iv)*A(2)/V3-KME*A(3)/V3 Eq 2 In NONMEM, we coded this as follows: DADT(3)=KMP *A(2)/V2-KME*A(3) Eq 3 Please note that DADT(3) in Eq 3, actually, is dC3/dt (a rate of concentration instead of amount), and KMP in Eq 3 = KMP(iv) x V2/V3 in Eq 1. In other words, KMP is a composite parameter of both volumn ratio and molecular weight ratio. If there are IV data for both parent and metabolite after administrations of parent and metabolite seperately, the true disposition parameters can be estimated for both. By converting the concentration unit to molar, we can estimate formation fraction of parent to metabolite. Jun Shi Clinical Pharmacology and Drug Dynamics Forest Research Institute Rm18-35 Harborside Financial Center-Plaza V Jersey City, NJ 07311 Tel: 201-427-8044 Fax: 201-427-8498 Email: [EMAIL PROTECTED] -----Original Message-----
Quoted reply history
From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of [EMAIL PROTECTED] Sent: Tuesday, February 13, 2007 9:02 AM To: Nmusers (E-mail); [EMAIL PROTECTED] Subject: RE: [NMusers] Simultaneous drug and metabolite POPPK I have a question for those who submitted these two examples - Did you transform the data into micromolar quantities? It is not clear from the examples. I have not done much parent/metabolite modeling (just lucky I guess) but it seems to me that one would have to work in molar units for these models to be valid. Can someone comment on this? Mike ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Michael J. Fossler, Pharm. D., Ph. D., F.C.P. Director Clinical Pharmacokinetics, Modeling & Simulation GlaxoSmithKline (610) 270 - 4797 FAX: (610) 270-5962 Cell: (443) 350-1194 [EMAIL PROTECTED] ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Feb 12, 2007 Vijay V. Upreti Simultaneous drug and metabolite POPPK
Feb 13, 2007 Johan Rosenborg RE: Simultaneous drug and metabolite POPPK
Feb 13, 2007 Urien RE: Simultaneous drug and metabolite POPPK
Feb 13, 2007 Michael Fossler RE: Simultaneous drug and metabolite POPPK
Feb 13, 2007 Alan Xiao RE: Simultaneous drug and metabolite POPPK
Feb 13, 2007 Liping Zhang Re: Simultaneous drug and metabolite POPPK
Feb 13, 2007 Jun Shi RE: Simultaneous drug and metabolite POPPK
Feb 13, 2007 Stockis Armel RE: Simultaneous drug and metabolite POPPK
Feb 13, 2007 Serge Guzy RE: Simultaneous drug and metabolite POPPK
Feb 14, 2007 Jun Shi RE: Simultaneous drug and metabolite POPPK
Feb 14, 2007 Michael Fossler RE: Simultaneous drug and metabolite POPPK
Feb 14, 2007 Alan Xiao RE: Simultaneous drug and metabolite POPPK